UPS says it can handle vaccine rollout, holiday parcel rush

From Transport Topics.

UPS Inc. said it has the capacity to handle the rollout of coronavirus vaccines and an unprecedented holiday package rush this month after investments in automation, tracking technology and dry-ice production.

The courier is the primary end-to-end distributor for Pfizer Inc.’s vaccine, as well as for kits to prepare the shots and dry ice shipments to keep the inoculations at extremely cold temperatures, UPS sales chief Kate Gutmann said in an interview. The vaccine and kits will have tracking devices that allow shipments to be monitored at all times.

“We’re planning enough capacity on the ground and in the air to make sure that there is no limit around the UPS side,” Gutmann said.

The initial vaccine shipments will coincide with the busiest shipping weeks of an extraordinary peak season in which virus-averse consumers are going online to order a record deluge of goods for home delivery. U.S. approval of the Pfizer vaccine is expected soon, now that the Food and Drug Administration has published a report saying there are no safety concerns to prevent its authorization.

See the complete article from Transport Topics online.